These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11699689)

  • 1. Seed implant brachytherapy for prostate cancer.
    D'Souza D; Zelefsky MJ
    CMAJ; 2001 Oct; 165(8):1003-4. PubMed ID: 11699689
    [No Abstract]   [Full Text] [Related]  

  • 2. Seed implant brachytherapy for prostate cancer.
    Halperin R
    CMAJ; 2001 Oct; 165(8):1003; author reply 1004. PubMed ID: 11699690
    [No Abstract]   [Full Text] [Related]  

  • 3. Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer.
    Langley SE; Laing RW
    Prostate Cancer Prostatic Dis; 2004; 7(3):201-7. PubMed ID: 15184864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is an 192Ir permanent seed implant feasible for prostate brachytherapy?
    Glasgow GP; Dogan N; Mohideen N
    Brachytherapy; 2002; 1(4):195-203. PubMed ID: 15062167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permanent prostate brachytherapy for Japanese men: results from initial 100 patients with prostate cancer.
    Okaneya T; Nishizawa S; Nakayama T; Kamigaito T; Hashida I; Hosaka N
    Int J Urol; 2007 Jul; 14(7):602-6. PubMed ID: 17645602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients.
    Cosset JM; Flam T; Thiounn N; Gomme S; Rosenwald JC; Asselain B; Pontvert D; Henni M; Debre B; Chauveinc L
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1042-8. PubMed ID: 18339488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
    Kulkarni GS; Lockwood G; Evans A; Toi A; Trachtenberg J; Jewett MA; Finelli A; Fleshner NE
    Cancer; 2007 Jun; 109(12):2432-8. PubMed ID: 17497649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer.
    Ash D; Al-Qaisieh B; Bottomley D; Carey B; Joseph J
    Radiother Oncol; 2005 Jun; 75(3):303-6. PubMed ID: 15890423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing treatment decisions in patients with low risk prostate cancer referred to a brachytherapy clinic.
    Taussky D; Liu A; Abrahamowicz M; Léger-Bélanger E; Bahary JP; Beauchemin MC; Nguyen TV; Donath D; Saad F
    Can J Urol; 2008 Dec; 15(6):4415-20. PubMed ID: 19046495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
    Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
    Kollmeier MA; Stock RG; Cesaretti J; Stone NN
    J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: a review of the H. Lee Moffitt Cancer Center experience.
    Torres-Roca JF; Cantor AB; Shukla S; Montejo ME; Friedland J; Seigne JD; Heysek R; Pow-Sang J
    Urol Oncol; 2006; 24(5):384-90. PubMed ID: 16962486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
    Gutman S; Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Adamovich E
    BJU Int; 2006 Jan; 97(1):62-8. PubMed ID: 16336330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Technique of intraoperative planning in prostatic brachytherapy with permanent implants of 125I or 103Pd].
    Prada Gómez PJ; Juan Rijo G; Hevia Suarez M; Abascal García JM; Abascal García R
    Arch Esp Urol; 2002 Dec; 55(10):1217-23; discussion 1223-4. PubMed ID: 12611219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State-of-the-art: prostate LDR brachytherapy.
    Voulgaris S; Nobes JP; Laing RW; Langley SE
    Prostate Cancer Prostatic Dis; 2008; 11(3):237-40. PubMed ID: 18364676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States.
    Frank SJ; Grimm PD; Sylvester JE; Merrick GS; Davis BJ; Zietman A; Moran BJ; Beyer DC; Roach M; Clarke DH; Stock RG; Robert Lee W; Michalski JM; Wallner KE; Hurwitz M; Potters L; Kuban DA; Prestidge BR; Vera R; Hathaway S; Blasko JC
    Brachytherapy; 2007; 6(1):2-8. PubMed ID: 17284379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
    Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose rate brachytherapy for prostate cancer.
    Hoskin P
    Cancer Radiother; 2008 Nov; 12(6-7):512-4. PubMed ID: 18755623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permanent prostate seed brachytherapy: a current perspective on the evolution of the technique and its application.
    Sahgal A; Roach M
    Nat Clin Pract Urol; 2007 Dec; 4(12):658-70. PubMed ID: 18059346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.